Stock Market News3 months Pfizer Secures Approval for Hemophilia Drug Hympavzi in the EU Zacks
Following approval from the European Commission, PFE’s Hympavzi becomes the first hemophilia medicine in the European Union to be administered via a pre-filled, auto-injector pen.
X